Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models

By Gabizon Alberto   Tzemach Dinah   Mak Lidia   Bronstein Moshe   Horowitz Aviva T.  

Journal of Drug Targeting, Vol. 10, Iss. 7, 2002-01 ,pp. : 539-548

Informa Healthcare

Access to resources Recommend Favorite

Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice

By Lee Gee Young   Park Kyeongsoon   Nam Jong Hee   Kim Sang Yoon   Byun Youngro  

Journal of Drug Targeting, Vol. 14, Iss. 10, 2006-12 ,pp. : 707-716

Informa Healthcare

Access to resources Recommend Favorite

Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice

By Hagtvet Eirik   Evjen Tove J.   Olsen Dag Rune   Fossheim Sigrid L.   Nilssen Esben A.  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 701-708

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies

By Gabizon A.   Shmeeda H.  

Clinical Pharmacokinetics, Vol. 42, Iss. 5, 2003-01 ,pp. : 419-436

Adis International

Access to resources Recommend Favorite

Enhancement of antitumor effect of doxorubicin by its complexation with γ-cyclodextrin in pegylated liposomes

By Arima Hidetoshi   Hagiwara Yoshiyuki   Hirayama Fumitoshi   Uekama Kaneto  

Journal of Drug Targeting, Vol. 14, Iss. 4, 2006-05 ,pp. : 225-232

Informa Healthcare

Access to resources Recommend Favorite